Impact of prediabetes and diabetes on 3-year outcome of patients treated with new-generation drug-eluting stents in two large-scale randomized clinical trials

BACKGROUND: Diabetes is associated with adverse outcomes after percutaneous coronary intervention with drug-eluting stents (DES), but for prediabetes this association has not been definitely established. Furthermore, in patients with prediabetes treated with contemporary stents, bleeding data are la...

Descripción completa

Detalles Bibliográficos
Autores principales: Ploumen, Eline H., Pinxterhuis, Tineke H., Zocca, Paolo, Roguin, Ariel, Anthonio, Rutger L., Schotborgh, Carl E., Benit, Edouard, Aminian, Adel, Danse, Peter W., Doggen, Carine J. M., von Birgelen, Clemens, Kok, Marlies M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8557556/
https://www.ncbi.nlm.nih.gov/pubmed/34717627
http://dx.doi.org/10.1186/s12933-021-01405-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8557556/
https://www.ncbi.nlm.nih.gov/pubmed/34717627
http://dx.doi.org/10.1186/s12933-021-01405-4

Ejemplares similares